×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Sarah Boyce

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOSep 05, 2025Option/RSU Exercise$1.2450,00062,000355,871Sep 05, 2025, 06:56 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOSep 05, 2025Sale$49.9550,0002,497,435305,871Sep 05, 2025, 06:56 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 28, 2025Option/RSU Exercise$1.2425,00031,000330,871Aug 29, 2025, 04:28 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 28, 2025Sale$49.3925,0001,234,700305,871Aug 29, 2025, 04:28 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMar 20, 2025Sale$31.0631,540979,563305,871Mar 21, 2025, 06:42 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJan 21, 2025Sale$28.5910,397297,291343,070Jan 23, 2025, 08:10 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEODec 18, 2024Sale$32.6631,8551,040,384265,308Dec 19, 2024, 06:15 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOSep 23, 2024Sale$44.0032,8801,446,723234,663Sep 23, 2024, 09:01 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 06, 2024Sale$43.3528,0001,213,822205,043Aug 07, 2024, 05:46 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 06, 2024Option/RSU Exercise$1.2428,00034,720233,043Aug 07, 2024, 05:46 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJul 09, 2024Option/RSU Exercise$1.2428,00034,720233,043Jul 11, 2024, 04:07 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJul 09, 2024Sale$39.9328,0001,118,082205,043Jul 11, 2024, 04:07 PM
OABIOmniAb, Inc.Sarah BoyceDirectorJun 18, 2024Option/RSU Exercise-20,000-68,381Jun 21, 2024, 05:01 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 18, 2024Sale$39.1332,0741,255,040142,543Jun 20, 2024, 06:47 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 12, 2024Sale$35.73100,0003,573,020112,117Jun 14, 2024, 06:58 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 13, 2024Option/RSU Exercise$1.24164,233203,649276,350Jun 14, 2024, 06:58 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 13, 2024Sale$40.08164,2336,581,802112,117Jun 14, 2024, 06:58 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 14, 2024Option/RSU Exercise$1.2435,76744,351147,884Jun 14, 2024, 06:58 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 14, 2024Sale$40.0835,7671,433,484112,117Jun 14, 2024, 06:58 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 12, 2024Option/RSU Exercise$1.24100,000124,000212,117Jun 14, 2024, 06:58 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 04, 2024Option/RSU Exercise$1.2428,00034,720140,117Jun 05, 2024, 05:46 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJun 04, 2024Sale$27.4228,000767,780112,117Jun 05, 2024, 05:46 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMay 07, 2024Option/RSU Exercise$1.2428,00034,720140,117May 07, 2024, 09:52 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMay 07, 2024Sale$25.5428,000715,050112,117May 07, 2024, 09:52 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOApr 02, 2024Sale$26.2528,000734,919112,117Apr 03, 2024, 06:16 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOApr 02, 2024Option/RSU Exercise$1.2428,00034,720140,117Apr 03, 2024, 06:16 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMar 08, 2024Option/RSU Exercise$1.2484,000104,160196,117Mar 12, 2024, 05:29 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMar 08, 2024Sale$21.3984,0001,796,710112,117Mar 12, 2024, 05:29 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMar 12, 2024Option/RSU Exercise$1.2428,00034,720140,117Mar 12, 2024, 05:29 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMar 12, 2024Sale$22.6328,000633,682112,117Mar 12, 2024, 05:29 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMar 01, 2024Option/RSU Exercise$1.2484,000104,160196,117Mar 05, 2024, 04:53 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOMar 01, 2024Sale$20.1384,0001,691,306112,117Mar 05, 2024, 04:53 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOJan 22, 2024Sale$10.135,09251,58244,008Jan 23, 2024, 03:13 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOFeb 03, 2023Option/RSU Exercise$1.243,2213,99456,573Feb 03, 2023, 05:26 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOFeb 03, 2023Sale$24.263,22178,14153,352Feb 03, 2023, 05:26 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOFeb 01, 2023Option/RSU Exercise$1.249001,11654,252Feb 03, 2023, 05:26 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOFeb 01, 2023Sale$24.2790021,84453,352Feb 03, 2023, 05:26 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOFeb 02, 2023Option/RSU Exercise$1.2445,87956,89099,231Feb 03, 2023, 05:26 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOFeb 02, 2023Sale$24.3645,8791,117,74153,352Feb 03, 2023, 05:26 PM
OABIOmniAb, Inc.Sarah BoyceDirectorNov 09, 2022Buy$2.7421,00057,59721,000Nov 14, 2022, 04:30 PM
OABIOmniAb, Inc.Sarah BoyceDirectorNov 10, 2022Buy$2.9215,00043,80036,000Nov 14, 2022, 04:30 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 24, 2022Option/RSU Exercise$1.2435,04543,45635,045Aug 26, 2022, 07:29 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 24, 2022Sale$22.8035,045798,9240Aug 26, 2022, 07:29 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 25, 2022Option/RSU Exercise$1.2414,85518,42014,855Aug 26, 2022, 07:29 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 25, 2022Sale$23.0714,855342,6900Aug 26, 2022, 07:29 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 15, 2022Sale$22.471002,2470Aug 17, 2022, 09:40 PM
RNAAvidity Biosciences, Inc.Sarah BoycePresident and CEOAug 15, 2022Option/RSU Exercise$1.24100124100Aug 17, 2022, 09:40 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 15, 2018Option/RSU Exercise-5,367-11,127Jan 17, 2018, 09:23 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 16, 2018Sale$51.762,196113,6658,931Jan 17, 2018, 09:23 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 01, 2018Other Acquisition or Disposition$42.7649120,9935,760Jan 02, 2018, 08:45 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJul 01, 2017Other Acquisition or Disposition$40.66176915,269Jul 03, 2017, 05:35 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 15, 2017Option/RSU Exercise-3,483-5,758Jan 18, 2017, 06:48 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 17, 2017Sale$46.291,36163,0015,252Jan 18, 2017, 06:48 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 01, 2017Other Acquisition or Disposition$20.7699220,5913,130Jan 04, 2017, 06:35 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJul 01, 2016Other Acquisition or Disposition$20.764038,3652,138Jul 01, 2016, 08:18 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 15, 2016Option/RSU Exercise-2,188-2,607Jan 19, 2016, 08:08 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 19, 2016Sale$41.4687236,1511,735Jan 19, 2016, 08:08 PM
IONSIONIS PHARMACEUTICALS INCSarah BoyceChief Business OfficerJan 01, 2016Other Acquisition or Disposition$47.7141919,991419Jan 04, 2016, 09:21 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe